Abstract
A simple, fast, and highly selective RP-HPLC method was developed for the determination of Dapagliflozin (DAP) and Saxagliptin (SAX) in API and tablet dosage form. The separation was done using a Xterra RP18 (4.6×150 mm, 5 μm particle size) column with Acetonitrile: water (60:40). The isocratic elution mode at a flow rate of 1 mL/min, and the analytes were measured at 248 nm. The retention time for DAP and SAX were about 2.091 and 3.249 min, respectively. Calibration curves were found to be linear in the ranges of 100-500 μg/ml for DAP and 50-250 μg/ml for SAX, with correlation coefficients of 0.9998. The detection and quantification values for DAP was 3.0 and 9.98 μg/ml and SAX was 3.02 and 10 μg/ml respectively.References
1. https://pubchem.ncbi.nlm.nih.gov/compound/Dapagliflozin
2. https://pubchem.ncbi.nlm.nih.gov/compound/Saxagliptin
3. Mante GV, Gupta KR, Hemke AT. Estimation of Dapagliflozin from its Tablet Formulation by UV-Spectrophotometry. Pharm Methods 2017; 8, 2:102-7. Google Scholar
4. Prasad PBN, Satyanaryana K, Krishnamohan G. Development and Validation ofa Method for Simultaneous Determination of Metformin and Saxagliptin in a Formulation by RP-HPLC, American Journal of Analytical Chemistry 2015;6:841-50. Google Scholar
5. Yunoos M, Sankar DG. A validated stability indicating high-performance liquid chromatographic method for simultaneous determination of metformin Hcl and dapagliflozin in bulk drug and tablet dosage form, Asian J Pharm Clin Res. 2015;8:320-6. Google Scholar
6. Cumar RP, Vasudevan M, Deecaraman A. Validated RP-HPLC Method for Simultaneous estimation of Metformin and Saxagliptin in Tablets, Rasayan. J. Chem. 2012;2:137-41. Google Scholar
7. Konari SN, Jacob JT. Stability indicating validated RP-HPLC technique for the Analysis of Multicomponent anti-diabetic drug combos in pharmaceutical Dosage Forms, Karbala international journal of modern medicine 2015;1(1):39-48. Google Scholar
8. Prakash PP, Ramesh SK, Vikas VP, Vijay BJ, Patil NP. A New RP-HPLC Method for Determination of Metformin Hcl and Saxagliptin in Tablet Dosage Form, IJPBS 2012;2:161-7. Google Scholar
9. Srividya S, Swetha E, Veeresham C. Development and Validation of a High Performance Thin Layer Chromatographic Method for Quantitative Analysis of Saxagliptin, American Journal of Analytical Chemistry 2015;6:797-806. Google Scholar
10. El-Kimary EI, Hamdy DA, Mourad SS, Barary MA. HPTLC Determination of Three Gliptins in Binary mixtures with Metformin, Journal of Chromatographic Science, 2015;54(1):78-87. Google Scholar
11. Gao JW, Yuan YM, Lu YS, Yao MC. Development of a rapid UPLC-MS/MS method for quantification of saxagliptin in rat plasma and application to pharmacokinetic study, Biomed. Chromatography 2012;26(12):1482-7. Google Scholar
12. Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M et al. Validated LC–MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma, Bioanalysis, 2010;2(12):2001-9, 2010. Google Scholar
13. Batta N, Pilli NR, Derangula VR, Vurimindi HB, Damaramadugu R, Yejella RP. A Rapid and Sensitive LC-MS/MS Assay for the Determination of Saxagliptin and its Active Metabolite5-hydroxy Saxagliptin in Human Plasma and its Application to a Pharmacokinetic Study, Drug Res. 2015;65:133-40. Google Scholar
14. Sridhar L, Goutami P, Darshan DV, Ramakrishna K, Rao RN, Prabhakar S. LC-ESI-MS/MS studies on saxagliptin and its forced degradation Products, Anal. Methods 2014;6:8212-21. Google Scholar
15. Shah PA, Shah JV, Sanyal M, Shrivastav PS. LC–MS/MS analysis of metformin, saxagliptin and 5-hydroxy saxagliptin in human plasma and its pharmacokinetic study with a fixed-dose formulation in healthy Indian subjects, Biomed Chromatography, 2017;31:e3809. Google Scholar
16. ICH Harmonised Tripartite Guideline Validation of Analytical Procedures: Text and Methodology Q2 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, Geneva, 2005:1-13. Google Scholar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2018 Authors